Background: Several studies have been conducted in China in order to investigate the potential predictors of serofast state after treatment among syphilitic patients. However, there is a remarkable diversity among the results. This meta-analysis was conducted to assess potential predictors of serofast among syphilitic patients in China.Methods: International and national electronic databases were searched up to September 2013. Reference lists of re-trieved articles were also reviewed. Cohort or case-control studies addressing risk factors of serofast among syphilitic patients were included in this study.Results: We assessed 27 separate studies involving overall 6682 HIV-negative participants with syphilis of which 1962 remained in the serofast state. The serofast was positively associated with older age (Ptrend=0.001), female (summary risk ratio [sRR]=1.50, 95%CI: 1.34-1.68), latent syphilis (sRRlatent vs primary=3.17, 95%CI: 2.66-3.77; sRRlatent vs secondary=2.00, 95%CI: 1.48-2.69) as well as non-penicillin treatment (sRR=2.99, 95%CI: 2.45-3.67), but negatively associated with higher baseline titers (sRR>1: 32 vs ≤1: 32=0.63, 95%CI: 0.54-0.75). Compared with healthy group and serological cure group, respectively, the levels of CD4 (+), IL-2, and IL-6 among serofast patients were decreased (standardized mean difference [SMD]<0, P<0.05), but the levels of CD8 (+) and IL-10 were increased (SMD>0, P<0.05). Some studies also hinted the serofast was associated with subtypes i of treponema pallidum (TP) repeat gene (RR i vs d=4.67, 95%CI: 1.31-16.69) and TP occult infection.Conclusion: The age, gender, stage of infection, baseline titers, treatment drug, cellular immune suppression and dis-orders, TP occult infection and subtypes i of TP repeat gene should be considered as important predictors of serofast. However, until now the definition and mechanism of serofast has still been not clear.